J 2023

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients.

FOŘTOVÁ, Andrea; Václav HÖNIG; Jiří SALÁT; Martin PALUS; Martina PÝCHOVÁ et. al.

Základní údaje

Originální název

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients.

Autoři

FOŘTOVÁ, Andrea; Václav HÖNIG; Jiří SALÁT; Martin PALUS; Martina PÝCHOVÁ; Lenka KRBKOVÁ; Andrey V. BARKHASH; Michal F. KRIHA; Ales CHRDLE; Marie LIPOLDOVA a Daniel RŮŽEK

Vydání

Virus Research, Elsevier, 2023, 0168-1702

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10607 Virology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.500

Kód RIV

RIV/00216224:14310/23:00130311

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000920459100001

EID Scopus

2-s2.0-85145704854

Klíčová slova anglicky

Tick-borne encephalitis; Neuroinfection; Matrix matalloproteinase; Cerebrospinal fluid

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 2. 3. 2023 12:35, Mgr. Marie Novosadová Šípková, DiS.

Anotace

V originále

Matrix metalloproteinases (MMPs) play an important role in central nervous system infections. We analysed the levels of 8 different MMPs in the cerebrospinal fluid (CSF) of 89 adult patients infected with tick-borne encephalitis (TBE) virus and compared them with the levels in a control group. MMP-9 was the only MMP that showed significantly increased CSF levels in TBE patients. Serum MMP-9 levels were subsequently measured in 101 adult TBE patients at various time points during the neurological phase of TBE and at follow-up. In addition, serum MMP-9 was analysed in 37 paediatric TBE patients. Compared with control levels, both paediatric and adult TBE patients had significantly elevated serum MMP-9 levels. In most adult patients, serum MMP-9 levels peaked at hospital admission, with higher serum MMP-9 levels observed in patients with encephalitis than in patients with meningitis. Elevated serum MMP-9 levels were observed throughout hospitalisation but decreased to normal levels at follow-up. Serum MMP-9 levels correlated with clinical course, especially in patients heterozygous for the single-nucleotide polymorphism rs17576 (A/G; Gln279Arg) in the MMP9 gene. The results highlight the importance of MMP-9 in the pathogenesis of TBE and suggest that serum MMP-9 may serve as a promising bioindicator of TBE in both paediatric and adult TBE patients.